Skip to content
Home/Companies/Biotech/Invitris
Invitris

Invitris

Biotech·Germany·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Invitris?

Invitris is a German Biotech company, currently owned by 10x Founders since 2023.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
10x Founders
Investor
10x Founders
10x Founders Fund I · 2022 · VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.invitris.com

More from 10x Founders Fund I

Other portfolio companies in the same fund.

Arlequin
Active
Deep TechFrance· 2025
Cocrafter
Active
SaaSGermany· 2025
Lyceum
Lyceum
Active
Deep TechGermany· 2025
Noah
Active
FintechUK· 2025
Artisan
Artisan
Active
SoftwareUS· 2024
Beyond Presence
Beyond Presence
Active
SoftwareGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Invitris?

Invitris is currently owned by 10x Founders, through 10x Founders Fund I, since 2023.

When did 10x Founders acquire Invitris?

10x Founders acquired Invitris in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue